CS logo
small CS logo
Indywidualna Praktyka Lekarska Prof. Dr Hab. N. Med. Konrad Rejdak.

Lublin, Poland

About Indywidualna Praktyka Lekarska Prof. Dr Hab. N. Med. Konrad Rejdak.


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Indywidualna Praktyka Lekarska Prof. Dr Hab. N. Med. Konrad Rejdak.


During the past decade, Indywidualna Praktyka Lekarska Prof. Dr Hab. N. Med. Konrad Rejdak. conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Indywidualna Praktyka Lekarska Prof. Dr Hab. N. Med. Konrad Rejdak." #1 collaborator was "Prothena Biosciences Limited" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

Clinical Trials Conditions at Indywidualna Praktyka Lekarska Prof. Dr Hab. N. Med. Konrad Rejdak.


According to Clinical.Site data, the most researched conditions in "Indywidualna Praktyka Lekarska Prof. Dr Hab. N. Med. Konrad Rejdak." are "Multiple Sclerosis" (3 trials), "Multiple Sclerosis, Primary Progressive" (2 trials), "Alzheimer Disease" (1 trials), "Multiple Sclerosis, Relapsing-Remitting" (1 trials) and "Parkinsons Disease" (1 trials). Many other conditions were trialed in "Indywidualna Praktyka Lekarska Prof. Dr Hab. N. Med. Konrad Rejdak." in a lesser frequency.

Clinical Trials Intervention Types at Indywidualna Praktyka Lekarska Prof. Dr Hab. N. Med. Konrad Rejdak.


Most popular intervention types in "Indywidualna Praktyka Lekarska Prof. Dr Hab. N. Med. Konrad Rejdak." are "Drug" (9 trials). Other intervention types were less common.
The name of intervention was led by "Ocrelizumab" (6 trials), "Placebo" (3 trials), "Antihistamine" (2 trials), "Fenebrutinib" (2 trials) and "Methylprednisolone" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Indywidualna Praktyka Lekarska Prof. Dr Hab. N. Med. Konrad Rejdak.


The vast majority of trials in "Indywidualna Praktyka Lekarska Prof. Dr Hab. N. Med. Konrad Rejdak." are 9 trials for "All" genders.

Clinical Trials Status at Indywidualna Praktyka Lekarska Prof. Dr Hab. N. Med. Konrad Rejdak.


Currently, there are NaN active trials in "Indywidualna Praktyka Lekarska Prof. Dr Hab. N. Med. Konrad Rejdak.". undefined are not yet recruiting, 6 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Indywidualna Praktyka Lekarska Prof. Dr Hab. N. Med. Konrad Rejdak., undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Indywidualna Praktyka Lekarska Prof. Dr Hab. N. Med. Konrad Rejdak., 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Departments of Indywidualna Praktyka Lekarska Prof. Dr Hab. N. Med. Konrad Rejdak.


Indywidualna Praktyka Lekarska Prof. Dr Hab. N. Med. Konrad Rejdak. has several departments that took part in Clinical trials: "Gabinet Kardiologiczno-Internistyczny" - 3 trials, "Indywidualna Specjalistyczna Praktyka Lekarska Malgorzata Biedrzycka" - 2 trials